← Alle mensen

JN

Jaclyn Neely

6 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as eerstelijns treatment for unresectable hepatocellular car...
Lancet (London, England) · 24 mei 2025
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 april 2025
Nivolumab plus cabozantinib met of zonder ipilimumab bij HCC: CheckMate 9DW
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 maart 2023
Nivolumab versus sorafenib bij gevorderd HCC: CheckMate 459 fase III
The Lancet. Oncology · 2022-01
Nivolumab plus ipilimumab bij gevorderd HCC: CheckMate 040 cohort 4
JAMA oncology · 1 november 2020
Geïntegreerde veiligheidsanalyse van urelumab, agonistisch anti-CD137 antilichaam
Clinical cancer research : an official journal of the American Association for Cancer Research · 15 april 2017